Assenagon Asset Management S.A. Ultragenyx Pharmaceutical Inc. Transaction History
Assenagon Asset Management S.A.
- $54.8 Billion
- Q1 2025
A detailed history of Assenagon Asset Management S.A. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 215,890 shares of RARE stock, worth $7.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
215,890
Previous 69,273
211.65%
Holding current value
$7.7 Million
Previous $2.91 Million
168.26%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding RARE
# of Institutions
336Shares Held
88.9MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$356 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$200 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$148 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$115 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$93.4 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.5B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...